Clinical trial Recruiting at 6 sites Interventional Ages 18 and up

Can liver stiffness testing help detect high central venous pressure in heart failure patients

Official title: Performance of Liver Stiffness Measurement (LSM) by FibroScan® for the Diagnosis of Elevated Central Venous Pressure (CVP)

Run by Echosens · NCT07222813 · Data updated 2026-11-12

A non-invasive FibroScan test is being used to see if liver stiffness can indicate elevated central venous pressure in adults with heart failure.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment149 (estimated)
SponsorEchosens
Industry-sponsored
Locations7 sites (Los Angeles, California and 6 other locations)
StatusRecruiting
StartedApril 23, 2026
Main results expectedDecember 31, 2027
Study endsJanuary 15, 2028
Registry record updatedSeptember 23, 2026
Trial IDNCT07222813 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with suspected or diagnosed heart failure who are scheduled for right-sided heart catheterization.

Probably not a fit

Patients without elevated central venous pressure or with factors that interfere with liver elastography may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, cross-sectional study tests whether liver stiffness measurements by VCTE correlate with elevated central venous pressure in adults with suspected or diagnosed heart failure who are planned for right-sided heart catheterization. The study compares non-invasive liver elastography with invasive catheter data and standard echocardiography to explore a potential alternative for assessing congestion. It is global, prospective, and involves several sites to evaluate the feasibility and accuracy of this approach. The trial is sponsored by Echosens with collaborators and follows safety and consent procedures for adults. Data from this study could inform non-invasive strategies to manage heart failure congestion.

Why it matters

Potential benefit: If successful, patients may gain a non-invasive option to help detect congestion without invasive catheterization.

How similar studies have gone: Non-invasive liver elastography has shown promise in reflecting hemodynamic changes, but this exact application to detect elevated CVP in heart failure is being explored.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Have read, understood, and signed the informed consent form (ICF)
2. Be ≥18 years of age at the time of screening
3. Have suspected or diagnosed acute or chronic HF and be scheduled to undergo right-sided cardiac catheterization

Exclusion Criteria:

1. Inability to consent
2. Chronic liver disease (self-reported alcohol use \>14 drinks/week in females and \>21 drinks/week in males), positive hepatitis C virus serology, positive hepatitis B surface antigen, autoimmune hepatitis, hemochromatosis, or cholestatic disease)
3. BMI \>40 kg/m2
4. Fontan-type circulation
5. Ascites
6. Heart transplantation
7. Pregnancy, breastfeeding, or intent to become pregnant during the study
8. Intent to donate/bank or retrieve eggs (ova, oocytes) or donate sperm during the study

Where it's running

  • University of Minnesota
    Minneota, Minnesota, United States
    Recruiting
  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting
  • University of Texas Southwestern Medical Center - Clinical Heart and Vascular Center - West Campus Building 3 Location
    Dallas, Texas, United States
    Recruiting
  • Centre Hospitalier Universitaire (CHU) de Rennes - Hopital de Pontchaillou
    Rennes, Ile Et Vilaine, France
    Recruiting
  • Deutsches Herzzentrum der Charité (DHZC) - Klinik fuer Herz-, Thorax- und Gefaesschirurgie
    Berlin, Germany
    Recruiting
  • Uniwersytet Medyczny im. Piastow Slaskich we Wroclawiu, Instytut Chorob Serca
    Wroclaw, Basse-Silésie, Poland
    Recruiting
Show 1 more location
  • Keck Medicine of USC-Norris Healthcare Center - Transplant Clinic
    Los Angeles, California, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.